Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.

Proceedings of the National Academy of Sciences of the United States of America - 7 May 2013

Su Tung-Hung, Liu Chen-Hua, Liu Chun-Jen, Chen Chi-Ling, Ting Te-Tien, Tseng Tai-Chung, Chen Pei-Jer, Kao Jia-Horng, Chen Ding-Shinn

Abstract excerpt

MicroRNA-122 (miR-122) facilitates hepatitis C virus replication in vitro. Serum miR-122 has been implicated as a biomarker for various liver diseases; however, its role in chronic hepatitis C remains unclear. To address this issue, 126 patients with chronic hepatitis C who completed pegylated IF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Body Mass Index
Share to Hepatitis C, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to MicroRNAs

Share to Multivariate Analysis

Share to Polyethylene Glycols

Share to Ribavirin

Source

Open in PubMed Open full text

Identifiers

PMID: 23613588
DOI: 10.1073/pnas.1306138110
PMCID: PMC3651447

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23613588-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C.PMID 23613588Read ↗

Evaluation of miR-122 Serum Level and IFN-λ3 Genotypes in Patients with Chronic HCV and HCV-Infected Liver Transplant Candidate.Semantic proximity Read ↗

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patientsSemantic proximity Read ↗

MicroRNA-122 associates with serum apolipoprotein B but not liver fibrosis markers in CHC genotype 1 infection.Semantic proximity Read ↗

Severity of hepatitis C virus (genotype-3) infection positively correlates with circulating microRNA-122 in patients sera.Semantic proximity Read ↗

microRNA-122 Abundance in Hepatocellular Carcinoma and Non-Tumor Liver Tissue from Japanese Patients with Persistent HCV versus HBV InfectionSemantic proximity Read ↗

Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.Semantic proximity Read ↗

Circulating miR-122 as a Potential Biomarker of Liver DiseaseSemantic proximity Read ↗

Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122Semantic proximity Read ↗

Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapySemantic proximity Read ↗

Increased hepatic expression of miRNA-122 in patients infected with HCV genotype 3.Semantic proximity Read ↗

Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.Semantic proximity Read ↗

Hepatitis C virus' Achilles' heel--dependence on liver-specific microRNA miR-122.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.